Virtual twins could predict liver and heart risks
NCT ID NCT07430501
First seen Feb 26, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This observational study aims to create a detailed virtual model of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) to better understand how the disease progresses and to predict heart problems. Researchers will follow over 7,700 adults with MASLD, using tests and imaging to track liver changes and heart events. No treatment is given; the goal is to improve prediction and personalized management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vall d´Hebron Institute de Recerca (VHIR)
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.